Sinopharm Tech Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SEHK:8156 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
17 Nov 25	BuyHK$150,436	Pik Lun Heung	Individual	440,000	HK$0.34
14 Nov 25	BuyHK$9,501	Pik Lun Heung	Individual	30,000	HK$0.32
13 Nov 25	BuyHK$40,200	Pik Lun Heung	Individual	120,000	HK$0.33
12 Nov 25	BuyHK$35,398	Pik Lun Heung	Individual	110,000	HK$0.32
10 Nov 25	BuyHK$45,206	Pik Lun Heung	Individual	140,000	HK$0.32
06 Nov 25	BuyHK$2,800	Pik Lun Heung	Individual	10,000	HK$0.28
05 Nov 25	BuyHK$60,000	Pik Lun Heung	Individual	200,000	HK$0.30
04 Nov 25	BuyHK$17,700	Pik Lun Heung	Individual	60,000	HK$0.30
23 Oct 25	BuyHK$36,900	Pik Lun Heung	Individual	150,000	HK$0.25
23 Oct 25	BuyHK$54,009	Pik Lun Heung	Individual	220,000	HK$0.25
22 Oct 25	BuyHK$7,401	Pik Lun Heung	Individual	30,000	HK$0.25

Insider Trading Volume

Insider Buying: 8156 insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 8156?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	27,097,574	4.28%
General Public	121,036,361	19.1%
Individual Insiders	485,559,120	76.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 5 shareholders own 80.9% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
74.4%	Tak Cheung Yam	471,694,520	HK$162.7m	0%	no data
4.28%	Best Frontier Investments Limited	27,097,574	HK$9.3m	0%	no data
1.96%	Siu Hoi Tse	12,426,000	HK$4.3m	0%	no data
0.21%	Pik Lun Heung	1,360,000	HK$469.2k	0%	no data
0.012%	Yanjie Cheng	78,600	HK$27.1k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/11/24 00:13
End of Day Share Price	2025/11/24 00:00
Earnings	2025/06/30
Annual Earnings	2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sinopharm Tech Holdings Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.